Polycystic ovarian syndrome (PCOS): A significant contributor to the overall burden of type 2 diabetes in women

Journal of Women's Health

Volumn 16, Issue 2, 2007, Pages 191-197

  Talbott, Evelyn O ^a   Zborowski, Jeanne V ^a   Rager, Judith R ^a   Kip, Kevin E ^a   Xu, Xiaohui ^a   Orchard, Trevor J ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; EARLY DIAGNOSIS; EXPOSURE; FEMALE; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; WOMEN'S HEALTH;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES; WOMEN'S HEALTH;

EID: 34047242577     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0098     Document Type: Article

References (28)

1. Clayton RN, Ogden V, Hodgkinson J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992;37:127.
2. Franks S. Polycystic ovarian syndrome. N Engl J Med 1995;333:853.
3. Dunaif A. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 1995;98:33S.
4. Zawadsky JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. Consensus Conference on PCOS. National Institute of Child Health and Disease, National Institutes of Health, Bethesda, MD: 1990. In: Current issues of endocrinology and metabolism: Polycystic ovary syndrome. Oxford: Blackwell Scientific Publications, 1992.
5. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarian syndrome. Fertil Steril 2004;81:19.
6. Chang PL, Lindheim SR, Lowre C, et al. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotopin-releasing hormone-agonist testing. J Clin Endocrinol Metab 2000;85:995.
7. Slowinska-Srzednicka J, Zgliczynski S, Wierzbicki M, et al. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 1991;14:569.
8. Mather KJ, Kwan F, Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 2000;73:150.
9. Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:942.
10. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987;65:499.
11. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997;18:774.
12. Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999;28:361.
13. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in PCOS: A prospective controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165.
14. Legro RS, Gnatuk CL, Kunselman AR, Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: A controlled study. J Clin Endocrinol Metab 2005;90:3236.
15. Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N, Rojanasakul A. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Gynaecol Obstet 2001;75:177.
16. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141.
17. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ. Relative risk of conversion of normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovary syndrome. Hum Reprod 2001;16:1995.
18. Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF. Risk of T2DM and impaired fasting glucose among PCOS subjects: Results of an 8-year follow-up. Curr Diabetes Rep 2006;6:77.
19. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51:581.
20. Talbott E, Guzick D, Clerici A, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 1995;15:821.
21. Talbott E, Clerici A, Berga SL, et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: Results of a case-control study. J Clin Epidemiol 1998;51:415.
22. Talbott EO, Sutton-Tyrrell K, Guzick DS, Kuller LH, McHugh KP, Zborowski JV. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000;20:2414.
23. Talbott EO, Zborowski JV, Sutton-Tyrrell K, McHugh-Pemu KP, Guzick D. Cardiovascular risk in women with polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001;28:111.
24. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953;19:531.]
25. Robbins M, Vaccarino V, Zhang H, Kasl SV. Socioeconomic status and diagnosed diabetes incidence. Diabetes Res Clin Pract 2005;68:230.
26. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk of diabetes mellitus in the United States. JAMA 2006;290:1884.
27. Peppard HR, Iuorno MJ, Marfori J, Nestler JE. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 2001;24:1050.
28. Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol 2000;52:81.